Skip to main content
. 2021 Jun 14;6(3):135–143. doi: 10.1016/j.synbio.2021.06.002

Fig. 4.

Fig. 4

The significantly different gene families and KEGG pathways between COVID-19 (Case) and non-COVID-19 (Control) patients. (a) Heat map of differential gene families (Wilcoxon rank-sum test, p < 0.01) in the nasopharyngeal samples. Specific species contributing to the abundance of these gene families were labelled in the figure. The horizontal color bar indicates the group of each sample. (b) Boxplots of significantly different KEGG pathways in two groups and the pathway names were colored according to direction of enrichment. Red indicated to be enriched in COVID-19 (Case), while green indicated to be enriched in non- COVID-19 (Control). *, p < 0.05.